Illumina Acquires Moleculo, Pre-announces Q4 Revenue Growth of 8 Percent | GenomeWeb

This article has been updated from a previous version, which had incorrectly transposed the year-over-year and sequential growth percentages for fourth-quarter revenue.

SAN FRANCISCO (GenomeWeb News) - Illumina CEO Jay Flatley today announced at the JP Morgan Healthcare Conference here that the firm has acquired long-read sequencing technology firm Moleculo for an undisclosed amount.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: statistical approach to examine intra-tumor heterogeneity, new genetic condition called otulipenia, and more.

Blood tests looking for biomarker changes could catch mental illnesses earlier, Newsweek reports.

DNA testing offers Korean adoptees a way to find their birth parents that sidesteps bureaucratic red tape, according to the New York Times.

A National Institutes of Health researcher has filed an Equal Employment Opportunity complaint against the agency, the Washington Post reports.